Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Fortune who wrote (663)	10/29/1998 1:24:00 PM
From: xbrent	Read Replies (3) \| Respond to of 1286

Volume so far x 4 is 280,000, not especially heavy. Apparently the Company CEO wanted off the BB. If you can believe this one they submitted the reverse it to the NASDAQ and it happened alot quicker than they thought. That is the reason stated for the poor communication with shareholders. Apparently the Company just wants off the BB was the reason for the reverse. Tired of the stock being .60 one day and .30 the next etc. They are confident that it is a fine company and they are not worried. Not good for SI traders but since when do SI traders matter.

To: Mr. Fortune who wrote (663)	10/29/1998 1:35:00 PM
From: Lane Hall-Witt	Respond to of 1286

It's really hard to assess the company itself, at this point, since we obviously have been caught off guard by this. We just don't know what lies behind NBMX management's thinking on this. We can, however, assess the markets for their products; and there is some reason to be heartened by that. National Boston claims to have 15 percent of the Canadian dental market. According to the Canadian Dental Association Web site, there are 16,000 dentists in Canada. cda-adc.ca They also have claimed that they're aiming to reach 15 percent penetration in the U.S. dental market. According to the American Dental Association Web site, there are more than 153,000 dentists in the U.S. ada.org These obviously are substantial markets for the dental instruments. In addition to this, SafeShield can be sold to a number of industries, most notably the enormous healthcare and food-services sectors. I'm not very familiar with the competitive environment in the anti-microbial lotions market, but I am aware that the profit margins in this sector are quite substantial. (I have done consulting in healthcare materials management and so have some familiarity with the industry in general.) None of this is to say that National Boston is well established in these markets; I'm not sure how successful they have been up to this point. But it is to say that the company is positioned with important products in some very large markets. That could account for some of the buying we have seen, and also for the company's rather brash statement that it will be applying to the Nasdaq Small-Cap Exchange once it has filed its Form 10.